Get the tools used by (smart)
2
investors.
Get Started
Search
SP500
-5.8%
DOW
-5.4%
FTSE 100
-4.9%
NIKKEI
-2.6%
OIL
-6.0%
GOLD
-2.3%
Sign In
Watchlists
Ideas
Screener
Data Explorer
Charts
Saved Work
Collapse
Dr Reddy’s Laboratories Ltd
BSE:500124
India / Healthcare / Pharmaceuticals
Currency
₹
+ Add Watchlist
Overview
Dividends
Earnings
Models
Financials
Compare
Health
Charts
Income Statement
Balance Sheet
Cash Flow Statement
EBITDA Reconciliation
Net Income Reconciliation
Forecasts
Valuation Ratios
Income Statement
Fiscal Years
Fiscal Half
Fiscal Quarters
Year To Date
Latest Twelve Months
Fiscal Years
Ascending
Descending
Ascending
3 Years
5 Years
10 Years
5 Years
Millions
Billions
Thousands
Ones
Millions
Standard Size
Common Size
Growth Rate
Standard Size
2020-03-31
FY-4
2021-03-31
FY-3
2022-03-31
FY-2
2023-03-31
FY-1
2024-03-31
FY
Revenue
174,600.0
189,722.0
214,391.0
245,879.0
279,164.0
Revenue Growth (YoY)
13.5%
8.7%
13.0%
14.7%
13.5%
Cost of Revenues
-80,591.0
-86,645.0
-100,551.0
-106,536.0
-115,557.0
Gross Profit
94,009.0
103,077.0
113,840.0
139,343.0
163,607.0
Gross Profit Margin
53.8%
54.3%
53.1%
56.7%
58.6%
R&D Expenses
-15,410.0
-16,541.0
-17,482.0
-19,381.0
-22,873.0
Selling, General & Admin Expenses
-50,129.0
-54,650.0
-62,081.0
-68,026.0
-77,201.0
Other Inc / (Exp)
-10,343.0
-5,329.0
-1,986.0
8,679.0
7,770.0
Operating Expenses
-75,882.0
-76,520.0
-81,549.0
-78,728.0
-92,304.0
Operating Income
18,127.0
26,557.0
32,291.0
60,615.0
71,303.0
Net Interest Expenses
-95.0
-144.0
7.0
-248.0
567.0
EBT, Incl. Unusual Items
18,032.0
26,413.0
32,298.0
60,367.0
71,870.0
Earnings of Discontinued Ops.
-
-
-
-
-
Income Tax Expense
1,466.0
-9,175.0
-8,730.0
-15,300.0
-16,186.0
Net Income to Company
19,498.0
17,238.0
23,568.0
45,067.0
55,684.0
Minority Interest in Earnings
-
-
-
-
-
Net Income to Stockholders
19,498.0
17,238.0
23,568.0
45,067.0
55,684.0
Preferred Dividends & Other Adj.
0.0
0.0
0.0
0.0
0.0
Net Income to Common Excl Extra Items
19,498.0
17,238.0
23,568.0
45,067.0
55,684.0
Basic EPS (Cont. Ops)
23.53
20.79
28.42
54.29
66.93
Diluted EPS (Cont. Ops)
23.48
20.73
28.34
54.17
66.80
Weighted Average Basic Shares Out.
828.8
829.2
829.4
830.2
832.0
Weighted Average Diluted Shares Out.
830.4
831.6
831.7
831.9
833.5
EBITDA
41,785.0
45,706.0
47,743.0
65,173.0
79,006.0
EBIT
29,313.0
32,910.0
35,919.0
53,416.0
65,308.0
Revenue (Reported)
174,600.0
189,722.0
214,391.0
245,879.0
279,164.0
Operating Income (Reported)
15,993.0
24,280.0
29,476.0
57,144.0
67,729.0
Operating Income (Adjusted)
29,313.0
32,910.0
35,919.0
53,416.0
65,308.0
FY-4
FY-3
FY-2
FY-1
FY
0
1
2
3
4
presentment in Millions except per share data. All rights reserved.
Terms Of Use
1